These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23382159)

  • 1. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.
    Thomsen TT; Madsen LB; Hansson HH; Tomás EV; Charlwood D; Bygbjerg IC; Alifrangis M
    Am J Trop Med Hyg; 2013 Mar; 88(3):536-41. PubMed ID: 23382159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
    Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
    Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.
    Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
    Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
    J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania.
    Malmberg M; Ngasala B; Ferreira PE; Larsson E; Jovel I; Hjalmarsson A; Petzold M; Premji Z; Gil JP; Björkman A; Mårtensson A
    Malar J; 2013 Mar; 12():103. PubMed ID: 23506218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
    Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP
    PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy.
    Lobo E; de Sousa B; Rosa S; Figueiredo P; Lobo L; Pateira S; Fernandes N; Nogueira F
    Malar J; 2014 Aug; 13():300. PubMed ID: 25098280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.
    Baraka V; Tinto H; Valea I; Fitzhenry R; Delgado-Ratto C; Mbonye MK; Van Overmeir C; Rosanas-Urgell A; Van Geertruyden JP; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2015 Jan; 59(1):734-7. PubMed ID: 25403659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained
    Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
    Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D
    Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
    Legrand E; Yrinesi J; Ekala MT; Péneau J; Volney B; Berger F; Bouchier C; Bertani S; Musset L; Meynard JB; Mercereau-Puijalon O
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1382-9. PubMed ID: 22232280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
    Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
    PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
    Mbogo GW; Nankoberanyi S; Tukwasibwe S; Baliraine FN; Nsobya SL; Conrad MD; Arinaitwe E; Kamya M; Tappero J; Staedke SG; Dorsey G; Greenhouse B; Rosenthal PJ
    Am J Trop Med Hyg; 2014 Jul; 91(1):54-61. PubMed ID: 24799371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.
    Ndiaye M; Faye B; Tine R; Ndiaye JL; Lo A; Abiola A; Dieng Y; Ndiaye D; Hallett R; Alifrangis M; Gaye O
    Am J Trop Med Hyg; 2012 Oct; 87(4):640-645. PubMed ID: 22927495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.
    Thomsen TT; Ishengoma DS; Mmbando BP; Lusingu JP; Vestergaard LS; Theander TG; Lemnge MM; Bygbjerg IC; Alifrangis M
    Am J Trop Med Hyg; 2011 Dec; 85(6):979-83. PubMed ID: 22144430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.